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Introduction: Poststroke depression (PSD) is a common and detrimental condition affecting one-third of 
hemorrhagic and ischemic stroke survivors. Current guidelines recommend screening early in the stroke 
recovery period, with some suggesting it best to screen patients prior to discharge from the hospital.  
Purpose: The primary purpose of this qualtity improvement project was to determine if shifting 
administration of the inpatient depression screening from the stroke care coordinator to the nursing staff 
affected the number of overall missed (22.1%) and weekend-specific depression screenings (37%) for 
stroke patients at the author’s institution. Methods: Total number of stroke admissions compared to the 
number of completed depression screenings, total number of depression weekend screenings, total 
number of positive depression screenings, and total number of psychiatric referrals were compared pre 
and post intervention. A Likert scale-based survey along with two open-ended questions were 
administered to the nursing staff to determine whether there was a change in nursing knowledge about 
post stroke depression in addition to acceptability, feasibility, and qualitative feedback about the process 
change. Results: No statistically significant differences were noted in the total amount of missed 
depression screenings (22.1% vs. 18.8%), the amount of missed weekend screenings for depression (37% 
vs. 15.6%), or the number of psychiatric referrals (4.7% vs. 4.7%) in the pre and post implementation 
periods. Nurses’ knowledge about post stroke depression increased and the process change was well 
received. Conclusions: Administration of the depression screening by the nurses did not significantly 
change the number of overall or weekend depression screenings. The low number of positive screenings 
and psychiatric referrals in the immediate inpatient setting calls into question whether screening for 
depression this early is necessary and highlights the need for depression screenings at multiple points of 
care.  
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Implementation of the Patient-Health Questionnaire-9 (PHQ-9) Depression Screening Tool through the 
Nursing Discharge Process with Stroke Patients: A Quality Improvement Project 
Section I: Nature of the Problem 
Introduction/Purpose  
Depression is a significant global health challenge affecting 264 million people annually, worldwide 
(World Health Organization, 2020). Depression prevalence rates seem to vary with age and gender after 
stroke. Approximately, 5.5% of middle-aged to elderly males (55-74 years of age) and 7.5% of older 
females were diagnosed with depression after stroke (World Health Organization, 2020). On average, 
someone in the U.S. has a stroke every 40 seconds and someone dies of stroke approximately every four 
minutes (Mozaffarian et al., 2016). It is estimated that 2 million brain cells die every minute during a 
stroke. After a stroke episode, new brain cells form to compensate for the injury and form specialized 
contacts with other cells. These new connections may not always be functional or communicate properly 
with neighboring cells and other brain structures. The cascade of changes within the brain poststroke is 
associated with both poststroke recovery and risk for developing poststroke depression (PSD) and other 
neuropsychiatric disorders (Ferro, Caeiro, & Figueira, 2016). 
Depression can develop from several internal and external factors. Strokes can produce intense 
depressive symptoms during recovery and persist indefinitely unless adequately treated. Stroke survivors 
are typically sent to a rehabilitation facility or home after their acute care admission. It is important that 
the initial acute care facility screens individuals for symptoms of depression to compare screening results 
to their evaluation in the post-discharge period. Those who are not screened and provided further care 
related to psychological well-being often have higher rates of functional decline like disability, sleep 
disorders, poorer rehabilitation outcomes, cognitive impairment, social withdrawal and isolation, and a 
weaker overall outlook in all-cause mortality (Burton & Tyson, 2015; Hackett & Pickles, 2014; 
Jyotirekha & Rajanikant, 2018). Strokes often leave patients with varying neurological focal deficits like 
memory loss, speech pathologies, and physical weakness that interfere with their original activities of 
daily living. These changes may lead to feelings of helplessness, frustration, and depressive sequelae that 
substantially affect a person's recovery. It would be wise to use a depression-rating scale to increase 
diagnostic accuracy in targeting depression as it is often confused with varying neurological deficits such 
4 
IMPLEMENTATION OF THE PHQ-9 DEPRESSION SCREENING TOOL 
 
 
as general fatigue (Dar et al., 2017). The initial PSD screening is the starting point for working toward 
improvements in depression after stroke and ongoing management. 
 Both major depression at six months and elevated rates of mortality at 12 and 24 months have been 
predicted by early stroke related symptoms of depression within the first few weeks following mild-
moderate stroke (Li, Oakley, Li & Luo, 2018). Even so, the general prevalence of depression maintains at 
about 1/3 of all stroke survivors. This is important considering PSD is associated with poor functional 
outcomes, behavioral and cognitive changes, and increased caregiver stress/burden (Towfighi et al., 2017; 
Wang, Meyer, Graham & Whooley, 2018; Hackett & Pickles, 2014). Along with psychological insults 
that result from suffering a stroke, physical deficits multiply the anxiety and frustrations of daily living 
upon returning home from the hospital. If patients are not connected to resources after discharge from an 
acute care facility, many may fail to adapt to their new circumstances. Those with physical deficits, such 
as weaker limbs, loss of sensation, visual disturbances, balance trouble, and lack of mental clarity, may 
realize that they cannot live and complete the same lifestyle as efficiently as they once did before their 
stroke (Matsuzaki et al., 2015). In addition, those who suffer from PSD may be at risk forrecurrent stroke. 
A meta-analysis that examined 753 research articles included six final articles for analysis after 
completing exclusion criteria. It was discovered that stroke survivors who had PSD had a 48% higher risk 
of recurrent stroke suggesting that early measures to treat PSD could also help decrease recurrence of 
stroke (Wu et al., 2019). It has been suggestedthat stroke patients should not only receive routine 
depression screenings during their rehabilitation, but also prior to discharge from the original acute care 
hospital so they can receive the support needed (Lanctot et al., 2019; McIntosh, 2017).  
The setting for the following quality improvement (QI) project took place in a large, midwestern, 
comprehensive stroke certified and level II trauma facility with 381 private rooms. The facility admits 30-
60 stroke patients a month (SCC Stroke Admission Data, 2019-2020). Regarding the prior process for 
PSD screening, the stroke care coordinator (SCC) was tasked with implementing the depression screening 
tool to all patients who suffered either a hemorrhagic or ischemic stroke during their admission prior to 
discharge from the hospital. Although the SCC had been successful at implementing the screening 
process, many screens were missed, particularly during the weekends when the coordinator was not 
scheduled to work and would not develop a daily stroke patient list. Theoretically, if a patient were 
5 
IMPLEMENTATION OF THE PHQ-9 DEPRESSION SCREENING TOOL 
 
 
admitted late Friday for a stroke and discharged late Sunday, the SCC would have had no knowledge that 
the patient was admitted and would not have been screened for depression. Any medical professional 
including but not limited to social workers, physicians, nurse practitioners, physician assistants, case 
managers, and nurses who were trained in the knowledge of the PHQ-9 may administer the question set.  
To improve upon these missed opportunities to screen for depression, the following project details a 
plan to have the neuroscience nursing staff (NSRNs) implement the screenings as early as their patients 
are functionally and cognitively able prior to the patient being discharged from the hospital. The 
following objectives for the project included: 1. Decreasing the number of overall missed and weekend-
specific PHQ-9 screenings for stroke patients at the current facility; 2. Improving nursing knowledge of 
poststroke depression symptoms; 3. Increasing the number of patients who receive psychiatric referrals 
for depression prior to discharge; and 4. Obtaining staff feedback through surveys regarding the pros and 
cons of the PHQ-9 screening tool. With mandatory education provided to the NSRNs, stroke patients 
were routinely screened for depression before discharge throughout the week. In summary, the purpose of 
the clinical inquiry regarding PSD screening was to investigate how transitioning the role of PSD 
screening from the SCC to the NSRNs would affect overall rates of screenings and to offer 
recommendations regarding the importance of screening and its usefulness in the recovery process after 
stroke. 
Section II: Review of the Literature 
Problem Statement 
     PSD is a prevalent and detrimental aspect of survivorship. Although evidence exists 
demonstrating the potential for developing depression within the first weeks following stroke, the ideal 
timing to initiate screening remains unclear (Lanctot et al., 2019; Zhao et al., 2018; Wang, Meyer, 
Graham, & Whooley, 2018; Karamchandani et al., 2015; McIntosh, 2017; Powers et al., 2018). Despite 
inconclusive evidence defining a need to screen for depression in the acute care setting, an efficient 
screening process may still prove worthwhile in detecting a trend in depressive symptoms prior to being 
discharged to either rehab or to the community. The following PICO question addresses the problem and 
guides the basis for change: In persons recovering from an acute hemorrhagic or ischemic stroke (P), how 
does implementation of the PHQ-9 depression screening tool through the NSRN (I) compared to 
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implementation by the stroke care coordinator (C), affect the number of depression screenings, nursing 
knowledge of PSD symptoms, psychiatric referral rates, and provider satisfaction (O)? By using the 
neuroscience nurses, screenings were provided seven days a week to improve screening consistency and 
to hopefully ensure all patients are screened and receive an appropriate evaluation when warranted. 
Outcomes were measured through statistical comparison between the SCC’s 2019 screening data and the 
NSRNs 2020 data.             
Summary and Evaluation of Literature 
The following databases were utilized to perform the literature review: CINAHL, PubMED, 
Cochrane, and Embase. Searches included the following keywords/phrases: “Nurs*,” “Stroke,” “PHQ-9,” 
“Stroke,” “Depression,” “Screen*,” “Post-stroke,” “Tool,” and “Assess*.” Such wording was mixed and 
grouped in several ways to yield the best search result outcomes. The following outcomes were reported: 
“Post-stroke patients AND Screen* AND Depression AND Nurs* = 10 results,” “Post-stroke patients 
AND Screen* AND Depression = 54 Results (Last 5 Years = 27),” “Stroke patients AND Screen* AND 
Depression AND Nurs* = 52 Results (Last 5 years = 20),” and “Stroke patients AND Screen* AND 
Depression = 276 (Last 5 Years = 155).” Roughly 66 sources were saved that pertained to the relevant 
problem including National guidelines, research articles, systematic reviews, meta-analyses, and general 
literature reviews. Summarized below in Figure 1 and Figure 2 are the twelve primary articles that 
provided adequate evidence to support the need for efficient and consistent depression screening in 
poststroke patients within the acute care setting. 
Guidelines 
Several guidelines exist for PSD that slightly vary in recommendations for the use of depression 
screening in stroke patients. The Adult Guidelines for Stroke Rehab and Recovery from The American 
Heart Association (AHA)/American Stroke Association (ASA) recommends (class 1, level of evidence B) 
screening for cognitive deficits in all stroke survivors prior to discharge home (Winstein et al., 2016). 
Depression may develop because of these cognitive deficits and screening may identify a patient’s 
susceptibility for future depression. Although the guidelines represent individuals who are already present 
at rehab facilities due to stroke, it would be beneficial to screen individuals prior to discharge from the 
original acute hospital to address additional depression related needs prior to arriving at rehab. Through 
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the use of the AGREE II appraisal tool (Appendix C), the guideline was given a score of 87%, which is 
based off of several factors to determine the strength of support for the guideline.  
Evidence was updated in 2018 within the AHA/ASA guidelines for early management for acute 
ischemic stroke, which recommends class 1, level of evidence B-NR for the administration of a structured 
depression scale to routinely screen for poststroke depression, but the optimal timing of screening is 
uncertain (Powers et al., 2018). Class 1 evidence is defined as having the strongest benefit to risk ratio 
and is highly recommended for use as part of stroke care. A level of evidence scored as, “B-NR,” is 
defined as having moderate quality evidence from one or more non-randomized, well-designed and well-
executed studies, which may include meta-analyses. Using the AGREE II appraisal tool, the guideline 
was rated a 92%. 
Aside from the AHA/ASA guidelines for stroke care, the China Guidelines further described the 
importance of PSD. A correlative study conducted in China found 34.21% of stroke patients suffer from 
early onset PSD (Less than 2 weeks poststroke) (Zhao, et al., 2018). They explained that PSD symptoms 
occur parallel in stroke possibly because of direct brain injury or acute psychosocial response to stroke, 
but poststroke depressive disorder results from longer stroke sequelae that usually occurs closer to 6-
months poststroke. The China Guidelines detail that stroke symptoms should be assessed early after 
stroke to help track the eventual development of depression as a diagnosis. The Guidelines also explored 
the PHQ-9 as a valid screening tool for depression in stroke survivors, finding 91% sensitivity and 89% 
specificity with a cutoff score of 10. They recommended the PHQ-9 as a valuable and easy to administer 
tool for early screening of major depressive disorder and PSD. The AGREE II appraisal resulted in a 
score of 90%.  
In addition, the Canadian Stroke Best Practice Guidelines (CSBP) recommend that all people who 
have experienced a stroke should be screened for depression given the high prevalence of PSD (Level B) 
and the amount of evidence for treating symptomatic PSD (Lanctot, et al., 2019). They add that screening 
for PSD may take place at various stages in stroke care especially at transition points as time of onset can 
vary. The first stage is during the transfer from an inpatient acute care setting to rehab, the second is 
during rehab prior to returning to the community and lastly, during regular scheduled follow-up visits in 
the outpatient clinic setting. Our acute care hospital follows a similar recommendation for screening as 
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the initial screen occurs prior to discharge from the inpatient facility and screening is continued at follow-
up appointments with neurology as warranted. That said, the CSBP specify that ideal timing for screening 
is unclear, so it is best to provide repeated screening as needed at any level. The AGREE II appraisal 
resulted in a 90%.  
The National Institute for Health and Clinical Excellence (NICE) and the Royal College of 
Physicians (RCP) National Clinical Guidelines recommend routine assessment and management of mood 
and cognition after stroke. Similar to the CSBP, they recommend depression assessment using a 
standardized measure on at least three occasions including 1) Just before discharge or one month after 
stroke or at six-week follow-up; 2) Three months after stroke; 3) and six months after stroke (Gillham & 
Clark, 2011). They add that all stroke patients should be assessed for a mood disorder with simple, brief 
standard measure including the PHQ-9, which maintains alignment with the tool used in our current 
hospital system. The AGREE II appraisal score was 89% for this guideline.  
Literature Review 
Validation and evidence for the support of poststroke depression screening were addressed through 
guidelines that validated the use of different screening tools like the PHQ-9 (Figure 3) and articles that 
justified screening prior to discharge from acute inpatient facilities. Figure 1 shows an evaluation table of 
the evidence supporting use of PSD screening. One retrospective study demonstrated validation for 
screening through an early screening protocol provided by the nursing staff. The study discovered that of 
the 79 patients screened with the PHQ-9 between 0 and 7 days of admission by the neuroscience staff 
nurses, 48% were depressed (McIntosh, 2017). Unlike the previously mentioned study, the current facility 
was already implementing its own protocol, and the nurses were aware of depression screening from 
knowledge attained during annual stroke education. Allowing the nurses to implement the screening      
would potentially improve consistency by increasing the number of people available to screen these 
patients as opposed to one stroke coordinator.  
Although not everyone develops symptoms in the immediate poststroke period, the use of the 
efficient PHQ-9 should not be excluded. Another study not only emphasized the benefit for early 
screening but showed that PSD is not an exact science and patients need routine follow-up and screening 
for several months following their stroke. Researchers showed that 42.43% of screened-positive 
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individuals identified at inpatient rehab were clinically depressed six months later while at home during 
follow-up according to DSM-5 criteria for depression (Lewin-Richter, Volz, JÖbges, & Werheid, 2015). 
In addition, regression analysis showed that those with early depressive symptoms had a 43% increase for 
moderate depression at six months post-assessment. The earlier the healthcare team can begin the 
screening process, the better the chances of successful management of depression further along in the 
poststroke period. Although the above study used the General Depression Scale-15 (GDS-15) rather than 
the PHQ-9 and they did not assess patients in the acute inpatient setting poststroke, it shows that early 
depressive symptoms have a high chance of progressing to depression several months after being 
observed.  
Further, there is evidence suggesting PSD is best treated when pre-scheduled follow-up appointments 
are created in the immediate inpatient setting. During a retrospective comparison of stroke patients with 
the former group being from 2010 and current from 2012, researchers discovered that the addition of a 
pre-scheduled follow-up visits allowed for a higher percentage of patients to disclose information 
pertaining to mood (Berg, Hujala, Kari, & Tapiola, 2018). In the 2010 stroke group who did not receive 
any pre-scheduled follow-up appointments, less than 36% of patients expressed depressive symptoms up 
to their regular 18-month follow-up whereas those in the 2012 group showed that 77% of patients 
disclosed depressive symptoms within the same follow-up period. Researchers showed that routine 
screening after stroke can lead to greater diagnoses for PSD and pre-scheduled follow-ups help to assess 
individuals for symptoms of depression. Although the study largely examines patients months after their 
stroke, it emphasizes that routine depression screening is beneficial in this population. Even so, other 
studies have been able to demonstrate the potential need for early screening after stroke during an 
inpatient stay.    
Risk factors for PSD include but are not limited to the severity of the stroke, prior mental health 
issues, age, pre-morbid neurotic personality traits, social isolation and substance abuse (Babkair, 2017; 
Das & G.K., 2018). As most patients who suffer stroke develop at least one of these risk factors, it is 
essential that survivors are screened early to assess for depressive symptoms and any other concerns 
pertaining to their recovery. Not only does a person’s previous psychiatric history and personality traits 
affect the potential for PSD, but demographics and socioeconomic status also influence their risk. One 
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study that examined the predictive factors associated with PSD showed that of 546 stroke survivors, 17% 
were diagnosed with depression upon screening with the PHQ-9 tool (Hirata, Ovbiagele, Markovic, & 
Towfigi, 2016). Interestingly, after adjusting for sociodemographic variables, those who were 
impoverished and had three or more medical comorbidities were also associated with higher odds of PSD. 
PSD is influenced by many variables and factors outside of solely a stroke itself. Each of these other 
variables may contribute to the differences that patients experience regarding the timing and severity of 
depression after stroke.  
Regardless of timing, The US Department of Veterans Affairs and the Department of Defense 
Clinical Practice Guidelines for the Management of Stroke Rehabilitation recommend that all patients 
complete depression screening with trained individuals while using valid screening tools (Rogers, 2017). 
As no strict evidence showed that screening was most beneficial in the acute phase of PSD, no evidence 
refuted that such early timing was incorrect or detrimental to a patient. Evidence suggested that the PHQ-
9 was an effective and non-disruptive form of screening regarding nurse work-flow. If patients were      
not screened prior to leaving the hospital, they could have been living with depressive symptoms for an 
unknown period without the resources available to seek appropriate psychiatric treatment.  
Although there did not appear to be a specific tool created for screening stroke patients in the acute 
poststroke phase, it remained not only feasible but helpful to use the PHQ-9. A systematic review studied 
27 tools that exist for detecting depression after stroke. The most effective tools were categorized into 
three groups such as verbal self-report, the use of visual aids and observational tools. The PHQ-9 was 
among the most popular and well validated with strong clinical utility and possessing the best ability to 
detect severe depression (Burton & Tyson, 2015). Unfortunately, the review aimed to uncover the ideal 
cut-off scores for each of these tools in detecting PSD, but too many variables like using a broad cultural 
population with key differences in interpreting depression could have affected appropriate scoring 
thresholds.  
A meta-analysis of 24 studies found several screening tools with high sensitivity for detecting PSD, 
including the PHQ-9 (Meader, Moe-Byrne, Llewellyn, & Mitchell, 2014). Of the 24 studies, there were 
552 patients from three studies that used the PHQ-9 to identify depression after stroke. Compared to the 
other eight screening tools, the PHQ-9 tied for the highest sensitivity to detect any depression (86%) and 
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tied for 5th for the highest specificity. Like most of the other studies, it was rated, “Fair,” for ruling in 
clinical utility and, “Good,” for ruling out the clinical utility regarding any depression. 
Further validity is observed through a study conducted in the Thai population who used a translated 
Thai PHQ-9 to screen for depression in poststroke patients. A primary reason for using the PHQ-9 for 
PSD was because of the high sensitivity for depression and its ease of availability and translation into the 
Thai language. The study examined 115 patients comprising 63 males (54.8%) and 52 females (45.2%), 
with a mean age of 64 years. These researchers graded depression by assessing the previous two weeks 
for depressive symptoms. Overall, the mean Thai PHQ-9 score was 5.2 +/- 4.8 and according to DSM-5 
criteria for depression, 11 patients (9.6%) were diagnosed with depressive disorder, 12 patients (10.5%) 
were diagnosed with adjustment disorder with a depressed mood and the rest of the 92 patients (80%) 
were normal (Dajpratham et al., 2020). Of those in the depressive disorder group, eight (6.9%) were 
classified as having a major depressive disorder (MDD), two (1.7%) with an unspecified depressive 
disorder, and one (0.9%) with another specified depressive disorder. It was determined that the PHQ-9 
had acceptable properties for detecting a mixture of major depression and adjustment disorder in 
poststroke patients with a cutoff score of 6 signifying poststroke depression. 
Though the PHQ-9 is well-validated and widely used for depression, its true use maintains alignment 
with the DSM-V and asks patients about depressive symptoms within the previous two weeks. 
Researchers assessed 158 ischemic and intracranial hemorrhage patients after excluding those with any 
pre-existing medical conditions or language deficits. Instead of assessing patients for depression within 
the last two weeks, they modified the PHQ-9 to explore depressive symptoms during the immediate 
poststroke period with an average screening being performed within 2.5 days of admission 
(Karamchandani, 2015). During this modified period, the researchers maintained that roughly 1/3rd of all 
patients screened in the immediate poststroke period were depressed.  
Although other newer stroke depression-specific screening tools are being developed, the familiarity, 
validity, reliability, and efficiency of the PHQ-9 was suitable for the current population. One study that 
compared four depression tools through rigorous analysis examined the PHQ-9 and PHQ-2, the Hospital 
Anxiety and Depression Scale (HADS) and the GDS-15. Ultimately, the PHQ-9 presented the best 
balance of both sensitivity (81.8%) and specificity (97.1%), respectively (Prisnie et al., 2016). Other 
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researchers found that when comparing four different depression screening tools among 147 acute 
poststroke patients, the PHQ-9 showed a specificity of 87% (Wang et al., 2018). Although many other 
screening tools exist, the PHQ-9 consistently ranks among one of the most accurate and efficient tools for 
the poststroke setting.  
In addition, a prospective study from the Netherlands examined the PHQ-2 and PHQ-9 in 164 stroke 
patients who met the following inclusion criteria: healthy enough for testing, signed informed consent 
prior to discharge, absent of cognitive difficulties, fluent in English and Dutch, and did not present any 
psychiatric comorbidities (de Man-van Ginkel et al., 2012). Subjects were established originally at 
baseline (T0) and included anyone who met the inclusion criteria and suffered either an intracerebral 
hemorrhage or cerebral infarct. At 6-8 weeks poststroke (T1), patients were provided the PHQ-9 by the 
nurse followed by the composite international diagnostic interview by the lead researcher who was absent 
during the PHQ-9 administration. Of the 164 poststroke patients, 20 were diagnosed with depression. The 
PHQ-9 was most accurate with a cut-off score for depression ≥ 10 with specificity and sensitivity in this 
setting resulting as 0.78 and 0.80, respectively. The PHQ-2 was most accurate at a cut-off ≥ 2 with 
specificity and sensitivity at 0.76 and 0.75, respectively. Regardless of its use for screening or specifically 
identifying depression in the stroke population, the PHQ showed adequate ability to reveal depression.  
One study included a depression screening assessment that the researchers self-developed. This 
assessment tool was loosely derived from several validated tools and common symptoms observed in 
those diagnosed with PSD. The researchers tested their tool on 122 stroke survivors who met the criteria 
for depression according to the DSM-5 booklet. They accurately identified up to 36% of the sample and 
detected early symptoms of PSD within 14 days of the stroke occurrence (Li et al., 2016). The timeframe 
after stroke becomes increasingly important as some patients will attend inpatient rehab following their 
acute admission. It has been hypothesized that depressive symptoms become reinforced upon 
transitioning from inpatient rehab back into their home as personal awareness increases regarding the 
negative effects on a patient’s original everyday life. 
Critical Appraisal of Evidence 
Figure 2 shows the synthesis and levels of evidence for the articles describing the importance of 
PHQ-9 pertaining to PSD. Unfortunately, despite a fair amount of literature discussing PSD, there is not 
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overwhelming support for high levels of evidence. Despite recommendations from the AHA/ASA, CSBP, 
China Stroke Guidelines, NICE and RCP to screen new stroke patients as early as possible, there is not a 
definitive protocol on the exact timing and ideal personnel needed to conduct the screening (Mitchell, 
2015). Primary support for screening exists through the literature that explains the high prevalence of 
PSD and the need to establish psychiatric or neurological resources early in the plan of care (Meader et 
al., 2014; Wang et al., 2018; Choi, Tate, Rogers, Donahoe, & Hoffman, 2016). Seven of the twelve 
articles represent level III evidence with the remaining five articles including two articles each at levels 
IV and I and one level V article.  
To maintain an updated discussion, evidence was obtained from the previous five years to 2015. 
Only two of the twelve primary articles were published at an earlier date from 2012 and 2014. Each of 
these investigated the use of the PHQ-9 on stroke patients and showed its ability to be used as a valid tool. 
All studies included only adult subjects who suffered from stroke and eight of the twelve studies used the 
PHQ-9 as the intervention. Since the articles used adult stroke patients and half of them represented 
findings within acute care facilities, the evidence is generalizable to the adult stroke patients being used in 
this QI project. The general body of evidence supports the use of the PHQ-9 in stroke patients but the 
definitive benefit and appropriate timing in screening patients in the acute setting remains unclear. Of the 
12 articles, only four described direct use of RN staff to administer the PHQ-9 while the remaining 
articles either did not describe personnel who administered the test or presented data pulled from previous 
charts.  
Though screening demonstrates the ability to identify those who have or are susceptible to 
depression, researchers and clinicians want to know if it produces any change to the outcomes of 
depression. Recent evidence has shown that anyone susceptible through the screening process should 
have a management pathway that provides the patient with psychiatric professionals in the hospital and in 
outpatient clinics (Towfighi et al., 2017). The current use of screening at the facility triggers either 
depression education and providing patients with stroke resources or the nurse to contact the attending 
physician depending on the PHQ-9 score. The nurses were already aware of the consult process and                
were trained to follow an algorithm (Appendix B) to contact the provider or to present resources.  
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 Considering the high prevalence of PSD, it is reasonable to recommend its regular assessment and 
management in patients who have a stroke history, although causal mechanisms underlying associations 
with adverse outcomes require further clarification, as does the extent that interventions might modify 
risk elevation (Cai, Mueller, Li, Shen, & Stewart, 2019). The institutionally driven intervention to screen 
for depression in stroke patients, which is based off recommendations mostly from the AHA/ASA 
guidelines, maintains alignment with the current literature recommendations. RNs (when appropriately 
trained) are capable of implementing the PHQ-9 tool, the tool is valid for use in screening for PSD in 
stroke patients, and the earlier the identification of PSD, the earlier psychiatric care can be applied when 
warranted.  
Gaps in Evidence 
Although several articles and guidelines exist demonstrating the importance of using the PHQ-9 to 
assess for depression in stroke, only a small amount of literature focused on the delivery pathway of the 
screening tool. If the individual is a healthcare worker who knows how to interpret the scoring and who to 
consult for further evaluation, it seems valid for a variety of healthcare backgrounds to implement the 
tool, including nurses (McIntosh, 2017; Mitchell, 2015; Rogers, 2017; Dajpratham, 2020; DeMan-van 
Ginkel, 2012). The Joint Commission (TJC) has recently updated their inclusion criteria regarding 
comprehensive stroke certification (CSC). In their recent report, they have eliminated the absolute 
requirement for depression screening during the acute care setting (The Joint Commission, 2018). It 
remains a firm recommendation but strict depression screening is no longer a primary marker for 
certification. This change is likely for the variety of organizations who may present several forms for the 
assessment and screening for depression and or cognitive decline. Instead of strictly requiring a 
depression screen prior to discharge, they placed the assessment under an umbrella of important issues 
pertaining to psychological well-being. This allows institutions to maintain their assessment tools and 
protocols while still meeting the criteria for CSC. Associations like the AHA and ASA both show support 
for its significance and recommend its use, but screening may not be as time sensitive and not change 
process of care.  
Theoretical Framework 
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The Tidal Model theoretical framework (Appendix D) is a mid-range nursing theory developed 
primarily as a guide for practitioners to aid patients who have suffered an incident that has adversely 
affected their mental health. It helps people recover their lives after experiencing a breakdown by 
reclaiming the personal story of their stress and difficulty (Barker & Buchanan-Barker, 2010). As 
previously mentioned, a stroke patient’s recovery is often more than regaining physical strength and 
overcoming aphasia. The psychological insult and potential for depression makes a patient as vulnerable 
as someone who may have suffered from drug abuse, a life-changing loss of a family member or any 
other circumstance that drastically alters one’s original outlook on life (Barker & Buchanan, 2010). 
Implementation of the PHQ-9 is the first step in inquiring about a patient’s story or their current mental 
health state.  
Utility and Feasibility 
The neuroscience nurses (NSRNs) were well prepared to implement the screening tool and make the 
appropriate consults. As a result, the SCC was able to spend more time putting together data and plans to 
improve other aspects of stroke care, including the upcoming development of a stroke team. In addition, 
there is no added cost burden for changing the delivery pathway of the screening tool, but potentially cost 
saving as the coordinator will gain time throughout the week to tend to other duties. Further, the 
development of the stroke team would generate more relative value units (RVUs) for the hospital by 
having an advanced practice provider regularly round on the stroke patients each day.   
Time commitments were minimal and aside from the time RNs had to prioritize to implement the 
screening, only the SCC, the hospital statistician and RN leaders for each unit were required to prioritize 
some effort into the project through email correspondence, education, weekly screening audits, and data 
production. The nursing director provided final approval for the project to move forward.      
Recommendations Summary 
From the above literature review, no study directly compared depression screening outcomes in 
stroke patients among different types of providers. Most of the literature recommends that trained medical 
providers may effectively administer the PHQ-9 screening tool in stroke patients. Further, there is no 
ideal timing indicated to screen for PSD, but it should begin early in the poststroke recovery and be 
repeated a different time points during follow-up care (Winstein et al., 2016; Powers et al., 2018; Zhao, et 
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al., 2018; Kapoor, et al., 2019; Gillham & Clark, 2011). PSD affects between 12% and 72% of those who 
have suffered a stroke (Torrisi et al., 2018). Further, an updated systematic review with 28 new studies 
(Previous 51 studies totaled in 2005) found that 31% of stroke survivors developed depression up to five 
years after their initial stroke (Hackett & Pickles, 2014). Studies examining the prevalence of depression 
often present different time-points for its diagnosis, and PSD is case dependent, relying on many variables 
for its development. As previously described during the literature review, there was enough evidence 
from notable national guidelines and quality studies that showed the importance for depression screening 
in stroke patients. 
Section III: Methods 
Recommendations for Evaluation of an Implemented Evidence-based Practice Change 
The hospital’s neuroscience department previously utilized the SCC for all its depression screenings 
in stroke patients to maintain alignment with AHA/ASA guidelines for PSA screening recommendations. 
The SCC completed and tracked all stroke patients week-to-week. Although the SCC had been competent 
and successful in this endeavor, 22% of stroke patients went without being screened. This was largely due 
to the SCC not working over the weekend hours and being overburdened with too many stroke patients to 
interview on her own. With the SCC busy developing the stroke team and prioritizing time elsewhere, the 
NSRN staff could provide the PHQ-9 assessment, which would offer more coverage for screening in both 
the number of personnel available and the number of days present to provide screening. Depending on a 
patient’s score, the NSRNs followed the PSD screening algorithm (Appendix E) to provide the necessary 
resources for depression if warranted. 
Plan for Evaluation of the Evidence-based Practice Change  
Evidence-Base practice Model 
Evidence-based practice has evolved over the last 18 years from being the conscientious use of 
current best evidence in deciding about patient care to a broadened lifelong problem-solving approach 
integrating systematic synthesis of external evidence, one’clinical expertise, and internal evidence while 
respecting patient preferences (Melnyk & Fineout, 2015). The John’s Hopkins Nursing Evidence-Based 
Practice Model (JHNEBP) (Appendix B) is suited to work with the hospital’s neuroscience unit as a 
scaffolding for the supported intervention.  
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 The three phases of the JHNEBP include the practice question, evidence, and translation. The 
project was guided through the development of each phase. The practice question originally asked was, 
“Why are PHQ-9 screenings missed or filed as incomplete in poststroke patients within a stroke certified 
acute care hospital?” The scope extended as far as the NSRN’s ability to assess all stroke patients. A 
formal project charter, schedule, risk management, and communication plan was developed to help 
organize and maintain the timeline for project implementation. Upon final synthesis and appraisal of 
articles based on the seven levels of strength of evidence, recommendations were proposed to the 
stakeholders regarding whether research was consistent, compelling, conflicting or entirely insufficient 
for ongoing testing.  
Last, the translation phase of the JHNEBP used the findings from the evidence and allowed the team 
to determine the overall feasibility of how to implement the project with the specific patient population 
and the current timeline. The PHQ-9 is a short and rather easy tool to implement by NSRN. The tool did 
not affect the overall clinical processes already in place for discharging a patient, but added some 
additional charting and time along with any pertinent education about the results. Once the feasibility of 
the project was determined, resources were secured for subsequent implementation including: nursing 
staff support, education or training materials about the PHQ-9 and its delivery, and proper electronic 
medical record (EMR) charting. As the EMR already included a section for charting the PHQ-9, no other 
measures were taken to alter the current programs. Once the implementation was finished, an evaluation 
of screening compliance and nursing feedback surveys were completed, analyzed and disseminated. 
Setting and Participants 
The PHQ-9 was implemented through the NSRNs in a large, trauma level 2, CSC hospital. The 
hospital employs nurse practitioners, physicians, pharmacists, lab technicians, social workers, case 
managers, information technologists, registered nurses, and nurse managers among many other health 
care workers. The hospital admits between 30-60 total stroke patients a month. Most of the patient 
population comprises adults and families who are managed for acute illness and any accompanying 
chronic conditions. The participants specifically involved in this QI project included anyone admitted to 
the unit with a diagnosis ofstroke who was18 years of age or older from all ethnic backgrounds, 
socioeconomic, and education levels. Any stroke patient with aphasia, some form of dementia, or any 
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other variable that impeded the person’s ability to provide accurate answers to the screening test were not 
excluded. These patients were collected as, “Unable to assess due to…,” data. As, “Missed screenings,” 
were being tracked, it was important to include these patients since screening could have been, 
“Attempted,” but incomplete, which was not considered a, “Miss.” Such patients were deemed, “Unable 
to assess,” if they were not oriented to person, place, time and situation, too fatigued to engage in the 
assessment or clearly demonstrating some form of aphasic nature during routine neurological exams 
conducted by the NSRNs. Those who presented with inclusion criteria were discharged to a rehab facility 
that was determined through a combination of assessments from physical therapy, case management, and 
social work recommendations. If the inpatient facility could not screen patients because of their excluding 
symptoms, they were automatically logged in the EMR as, “Unable to assess,” and followed with more 
specific psychiatric care with the immediate rehab facility when warranted. 
Training 
Prior to publishing the education module, the author attended leadership meetings and spoke with the 
nursing leads for the intensive, progressive, and intermediate care units. First, it was determined that the 
best way to brief the NSRNs of the change was to attend and present at three nursing huddles for day and 
night shift within each of the units. Next, since all NSRNs had the potential to provide care to a stroke 
patient, each nurse was instructed to complete a PHQ-9 education module. The education module was 
developed using pertinent evidence from the literature with guided images, an algorithm and competency 
quiz. The module provided not only education regarding PSD but also directions detailing how the nurses 
were to identify, chart and record the appropriate PSD scores. Nursing and education leadership teams 
provided feedback and offered edits prior to the module’s launch to ensure accuracy of the material, 
grammatical correctness, and quiz questions.  
The module was not published until final approval was acknowledged by the neuroscience nursing 
director. The module was launched as an electronic presentation through the hospital’s education system, 
Healthstream. All NSRNs were required to complete the competency prior to administering the PHQ-9 
screening tool. To ensure adequate completion, nursing managers were notified if a nurse did not 
complete the education within the designated three-week period. The PHQ-9 is known as an easy-to-learn 
tool that does not require an in-person training session and the use of excessive personnel for education 
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(de Man-Van Ginkel et al., 2012). In addition, NSRNs were notified through email when an education 
class expired or was incomplete. Further, nursing managers sent weekly updates to the NSRNs with 
reminders to complete the mandatory education. Documentation was recorded for the total number of 
NSRNs who completed the training and the results of the educational assessment. The huddle briefings 
and education module allowed sufficient guidance and support for the nurses to feel confident in 
proceeding with the new intervention. 
Implementation 
Implementation of the PHQ-9 depression screening tool began on 4/23/2020 after each NSRN 
completed the mandatory education module. Any patients who were already admitted and required a 
PHQ-9 screening assessment were covered by the SCC. Close communication between the SCC with 
nursing staff enabled an efficient transition to avoid missing any patients. The PHQ-9 was presented to all 
eligible stroke patients during the period after admission as soon as the patient was cognitively and 
functionally able to complete the screening form. Upon obtaining a score, nurses were guided by the 
established scoring system and algorithm to provide education, stroke support services or potentially 
notify the appropriate medical provider as shown in Appendix E. The current psychiatric referral process 
was previously established and continued as screening transitioned into a nursing responsibility. Upon 
completion of the screening, the nurses used the algorithm (Appendix E) to guide decision making for the 
best patient care. If nurses were unsure about how to score a particular response, he or she would contact 
the charge nurse, myself, or the SCC for any further questions. As a result, patients either spoke with a 
psychiatrist when warranted, or were provided with resources and/or additional referrals, and scheduled 
follow-up appointments. When a positive result for suicidal ideation occurred, a constant attendant was 
placed with the patient in addition to the psychiatric consult and suicidal precautions for the rest of his or 
her stay. Descriptive and quantitative data were collected along with two open-ended questions directed 
toward the nursing staff to obtain qualitative feedback pertaining to the change in the process of 
depression screenings. 
Data was obtained and included the total stroke admissions, the total number of weekend stroke 
admissions, the frequency and  total number of completed PHQ-9 screenings, the total number of 
completed PHQ-9 screenings over the weekend, the number of excluded or aphasic patients, and 
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psychiatric referrals completed during the data acquisition period (4/23/2020 to 7/31/2020). Data obtained 
through the new NSRN delivery pathway was compared to the original baseline from the previous year 
during the same months originally completed by the SCC. Pre- and post-analysis comparison of the data 
was completed as a part of the statistical plan. 
In addition, further quantitative data was obtained through interpretation of Likert-scale statements 
provided to the nurses at the end of data collection within Healthstream. The survey was scored using a 
Likert-scale model for assessing the strength of the NSRN’s feelings on a statement. The scale offered the 
following scoring levels for feedback: 1) Strongly disagree; 2) Disagree; 3) Neutral; 4) Agree; 5) Strongly 
Agree. Scores were totaled and assessed to reveal the overall impression of the nurses for each statement. 
Feedback from the nurses pertaining to the new intervention was identified through the following 
statements: 1) “The implementation of the PHQ-9 at discharge was easy to administer.”; 2) The 
implementation of the PHQ-9 at discharge is beneficial for patients as a part of my practice as a nurse.”; 
3) “The implementation of the PHQ-9 at discharge offered accurate results.”; 4) “I felt prepared to present 
the PHQ-9 to stroke patients.”; 5) I feel confident in answering patient questions about the PHQ-9.     ”; 
and 6) I would recommend continuing the implementation of the PHQ-9.” The raw quantitative data 
obtained from the screenings pre and post-test along with the Likert-scale survey and open-ended 
statements provided ample feedback regarding the ability of the new screening pathway to fulfilling 
consistent and efficient depression screenings in stroke patients. 
Last, open-ended statements were provided to the NSRNs pertaining to the changes experienced. 
Nurses could freely describe their thought process and provide any feedback to the following statements: 
1) “Please explain any difficulties, frustrations or any other problems that occurred while implementing 
the PHQ-9;” 2) “Please explain any alternatives to how the PHQ-9 should be implemented or provide any 
suggestions to improve upon the new intervention.” These statements were provided as part of a post-
implementation assessment within the Healthstream education system and each answer was stored and 
logged. 
Potential Barriers, Organization, and Policy Driven Implications 
As the project was conducted in a large hospital within an acute care setting, several barriers were 
anticipated. First, it was imperative that NSRNs be trained and aware of the depression screening process 
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change. The large volume of nurses who administered the screenings could have presented variability in 
the approach during an interview session. Although the same questions were asked, it was important that 
strict rules were followed. A nurse was not to convince a patient that one answer was better than another 
or help guide the patient to an answer. The nurse was to allow the patient to think about their own 
perceptions about their mental well-being and independently decide. If the NSRN was unaware of this 
specific training, answers and data might have been inaccurate.  
There was not much resistance to implementing the PHQ-9 from the NSRNs. The explanation of the 
process at nursing huddles, presenting at annual neuroscience education classes, and developing a module 
for guidance improved the overall nurse, “Buy-in,” to move forward with the intervention. Even so, 
nursing leadership posed many questions and requested explanations for some quiz questions in the 
education module. After working together to ensure that each nursing leader accepted the edits for the 
Healthstream module, the PSD education was published. It takes an average of 17 years to translate 14% 
of original research into a usable benefit for patients and an average of 9 years for interventions 
recommended as evidence-based practices to be adopted (Tinkle, Kimbell, Haozous, Shuster, & 
Grochowski, 2013; Melnyk & Fineout, 2015). Although the NSRN moved forward with implementing 
the new task, there was never a specific option to refuse the implementation. That said, the surveys and 
open-ended questions provided after data collection offered a way to value their feedback regarding the 
added task as a part of the team and improvement process.  
Some studies showed difficulty obtaining consistent results when only using one form of depression 
screening, especially with patients who may exhibit some aphasic symptoms (Rogers, 2017; Robinson & 
Jorge, 2016). Accurate documentation regarding the patient’s poststroke condition and level of 
consciousness was acquired. NSRNs were to only complete screening on stroke patients who 
demonstrated competent neurologic status as a result from routine neurologic exams, which included 
assessment of orientation and ability to communicate. They were to mark the screening as, “Unable to 
assess,” even with the slightest evidence that a patient may not be able to communicate appropriately. 
Without proper neurologic assessment, it is possible that some NSRNs could have missed minor cognitive 
impairments that could have generated inaccurate screening results. To add to the difficulty, non-native 
English speakers were less likely able to participate in the screening process in the absence of an English-
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speaking family member or certified language interpreter. The project site sees approximately 74.7% 
Caucasian, 22.9% African American, and 2.5% of other races, which often include many who do not 
speak English as their native language. Although the NSRNs were trained in how to contact interpretative 
services, language barriers impeded accurate results and the ability to conduct the PHQ-2 or PHQ-9. Also, 
the use of non-certified staff may have led to mistranslation, while use of friends and family members 
may have resulted in the patient under-reporting depressive symptoms. 
Protection of Human Subjects 
The following project was granted exempt status by the Institutional Board Review (IRB).  
Data Collection/Evaluation 
The educational module was opened via Healthstream for the nurses to complete for three weeks. 
Implementation of the project change occurred on April 4/23/2020. The NSRNs responsible for caring for 
poststroke patients executed a depression screening assessment using the well-validated PHQ-9. The 
stroke patient list was evaluated at least three days a week (MWF) by me for the duration of data 
collection to ensure compliance with charting the PHQ-9 on stroke patients. If I could not review the list, 
the SCC was available to check patient scores in my absence. Descriptive data was collected each week 
and included the total number of subjects screened out of eligible patients, the average day each patient 
was screened and any psychiatric consults that resulted from screening. Typical follow-up scheduling and 
processes continued but were not included in the project outcomes.  
Data Analysis 
Project analysis was conducted at the termination of data collection. It took approximately another 
two weeks to obtain the final data from the hospital statistician. From approximately 9/3/2020 to 
9/11/2020, I along with The Ohio State University statistician facilitated the project analysis. Raw data 
from the pre-and posttest periods included the number of stroke admissions, the total number of 
completed PHQ-9 screenings, total stroke patients during the weekend versus the total screenings 
completed over the weekend (Saturday and Sunday), psychiatric referrals completed, the average day 
each patient was screened, and the number of those who could not be assessed because of symptoms like 
aphasia or confusion. Also, patients were recorded who demonstrated stroke symptoms without diagnosis 
23 
IMPLEMENTATION OF THE PHQ-9 DEPRESSION SCREENING TOOL 
 
 
of an acute stroke but had a history of previous stroke. This data provided further insight regarding how 
many potential patients with prior stroke could benefit from depression screening regardless of acuity. 
Unfortunately, this data was only showed with the recent 2020 group and was not tracked during the 
previous year. 
To assess the NSRN’s feedback, quantitative analysis was completed using a Likert-based scale 
consisting of six statements administered to the nurses at the end of the data collection period regarding 
usefulness of the screening and overall opinion on the implementation change as previously described. 
Further nursing feedback was collected with two open-ended statements provided to the NSRNs that 
inquired about feasibility of the intervention and any alternatives that may improve the process.  
The baseline data consisted of the patient’s age, gender, type of stroke, length of hospital stay, and 
average day screened. Nursing demographics were also obtained during the Healthstream education 
session and included their gender, age, years working within the neuroscience unit, and work status as a 
single hospital RN, flex RN or travel RN. Baseline data, audit data and the questionnaire results were 
described using frequencies, means, standard deviations, and percentages. To compare differences among 
the patient groups, chi-square testing was used for categorical baseline data. Statistical software was be 
used to perform the quantitative data analysis and a P < 0.05 with a 95% confidence interval. Data from 
the nursing questionnaire were presented as numbers with the corresponding percentage of nurses who 
agreed with a particular item on the questionnaire. The questionnaire was analyzed using descriptive 
statistics. 
Section IV: Findings 
Results/Outcomes 
Nursing Demographics 
As previously noted, demographic baseline data was obtained by the NSRN to demonstrate nursing 
gender, age, years working and full or part-time status. Upon completing the Healthstream poststroke 
depression module, there were 107 RN responses for the demographic questions. Of the 107, 87 female 
RNs (81.31%), 18 males (16.82%), 1 non-binary AND 1 RN who chose not to disclose their gender 
status. Most RNs who took the education were between 26-30 years old (29 total; 27.10%). The 
remaining ages included 26 RNs up to age 25 (24.30%), 27 RNs between 31-40 years old (25.23%), 19 
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RNs between the ages 41-50 (17.76%), 5 RNs between ages 51-60 (4.67%) and only 1 RN above 60 years 
of age. 
The NSRNs also demonstrated a less-experienced overall cohort, with most only having worked as 
an RN up to 3 years (54 RNs; 50.57%). Another 22 RNs had between 4-8 years of experience (20.56%), 
16 RNs had between 9-15 years (14.95%), 4 RNs had between 16-20 years (3.74%) and 11 RNs had over 
20 years of overall experience (10.28%). Last, data were obtained pertaining to employment status as 
either a flex RN, single hospital RN, or travel RN. As expected, most neuroscience RNs who took the 
PSD module worked only at the hospital using the new poststroke depression screening pathway through 
RNs. Of the 107, 97 RNs worked only at the hospital being studied (90.65%) and another 8 were flex 
RNs who worked at any of the three system hospitals designated between the data collection period 
(7.48%). There were only 2 traveling RNs who were stationed in the neuroscience unit during this 
designated time (1.87%).  Refer to Table 1.  
 Nursing PSD Education Test Results 
The PSD education module was required for all participating RNs. The average score was 84% 
(Healthstream Reports, 2020). The nurses had to take the test until they achieved at least an 80%. One 
hundred percent of nurses completed the education module and passed the competency test.  
PSD Quantitative Statistics 
2019 Data from Stroke Care Coordinator  
For 2019, the average patient age was 65 years with 74 total males and 98 females. Of these patients, 
31 were diagnosed with non-traumatic intracerebral hemorrhage and the remaining 141 were diagnosed 
with cerebral infarct. There were 172 eligible stroke patients that met criteria for the depression screening 
(NIME-73; NPUE-75; NIUE-24). Of the 172 patients, 134 (77.9%) were screened or attempted to be 
screened by the SCC, leaving 38 (22.1%) patients who were missed and never received an attempt at 
screening. There were 29 (16.9%) total patients unable to be screened due to factors like aphasia, 
confusion, loss of consciousness, or withdrawal of care. Further, of the 172 total patients, only 27 (15.7%) 
were discharged over the weekend (Saturday or Sunday) in 2019. Of these 27, 17 (63%) patients were 
screened and 10 (37%) were missed. For the 38 patients missed overall, 10 of these patients were missed 
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due to weekend discharges, or 26.3%. Last, there were 8 total psychiatric referrals (4.7%) either obtained 
directly because of screening or already pre-existing due to previous psychiatric history.  
Other data included were the average PHQ-9 and PHQ-2 scores for each unit, and the average overall 
day patients were screened. For the NIME in 2019, the average PHQ-9 and PHQ-2 scores were 2.1 and 
0.69, respectively; NPUE in 2019 average PHQ-9 and PHQ-2 scores were 1.1 and 0.28, respectively; and 
the NIUE in 2019 average PHQ-9 and PHQ-2 scores were 0. The overall average PHQ-9 score among all 
units was 1.05 and average PHQ-2 score was 0.32.  
Regarding the average day of screening, NIME patients were screened on an average of 1.5 days out 
of their average length of stay (LOS) of 3.87 days; NPUE patients were screened on an average of 3.4 
days out of their average LOS of 5.37 days; and NIUE patients were screened on an average of 9.4 days 
out of their average LOS of 11.4 days. Overall, patients were screened among all units on an average of 
4.8 days out of their total average LOS of 6.89 days. Refer to Table 2. 
2020 Data from NSRNs. For 2020, the average patient age was 70 years with 64 total males and 64 
females. Of these patients, 22 were diagnosed with non-traumatic intracerebral hemorrhage and the 
remaining 106 were diagnosed with cerebral infarct. There were 128 eligible stroke patients for 
depression screening (NIME-63; NPUE-46; NIUE-19). Of the 128 patients, 104 (81.25%) were screened 
or attempted to be screened by the neuroscience RNs, leaving 24 (18.8%) patients who were missed and 
never received an attempt at screening. There were 10 (7.8%) total patients unable to be screened due to 
factors like aphasia, confusion, loss of consciousness, or withdrawal of care. Further, of the 128 total 
patients, 32 (25%) were discharged over the weekend (Saturday or Sunday) in 2020. Of these 32, 27 
(83.37%) patients were screened and 5 (15.6%) were missed. For the 24 patients who were missed 
overall, 5 of these patients were missed because of weekend discharges, or 20.83%. Last, there were 6 
total psychiatric referrals (4.7%) either obtained directly as a result of screening or already pre-existing 
due to previous psychiatric history.  
For 2020, the average PHQ-9 and PHQ-2 scores for each unit and the average overall day patients 
were screened were obtained. For the NIME in 2020, the average PHQ-9 and PHQ-2 scores were 3.9 and 
1.2, respectively; NPUE in 2020 average PHQ-9 and PHQ-2 scores were 2.2 and 0.53, respectively; and 
26 
IMPLEMENTATION OF THE PHQ-9 DEPRESSION SCREENING TOOL 
 
 
the NIUE in 2020 average PHQ-9 and PHQ-2 scores were 1.9 and 0.86, respectively. The overall average 
PHQ-9 score among all units was 2.6 and average PHQ-2 score was 0.85.  
Patients in the NIME were screened on an average of 1.8 days out of their average LOS of 3.42 days; 
NPUE patients were screened on an average of 2.2 days out of their average LOS of 4.15 days; and NIUE 
patients were screened on an average of 4.2 days out of their average LOS of 7.1 days. Overall, patients 
were screened among all units on an average of 2.7 days out of their average LOS of 4.89 days. 
2019 and 2020 comparison data. When comparing the 2019 total screenings completed through the 
stroke care coordinator versus the screenings completed in 2020 through the neuroscience nurses, there 
was no statistically significant difference in the amount of missed screenings. There was a slight decrease 
in missed screenings from 22.1% to 18.8%, which demonstrated a minor improvement, but there were 
also 44 fewer patients screened in 2020. The overall p value was 0.56 for the data set.  
When comparing the 2019 weekend data set (Pre) to the 2020 data set (Post) pertaining to 
discharges, there was a significant decrease in the amount of missed screenings from 37% to only 15.6%. 
There were also 5 fewer patients discharged on the weekend in 2019 compared to 2020 showing an 
overall p value of 0.08.  
There were no significant differences in the number of psychiatric referral results from 2019 to 2020. 
Of the total stroke patients in 2019 (172) and 2020 (128), 4.7% of each group were referred for 
psychiatric consultation within the acute care setting, providing an overall p value of 0.99.  
Last, a final comparison study investigated the percentage of stroke patients screened who generated 
a score above the cut-off value (PHQ-9 > 4) for suspected depression. In the 2019 group, there were 103 
total PHQ-9 scores with only 13 patients (12.6%) who scored above a 4 warranting further notification of 
the attending physician or neurologist by the SCC. In 2020, of the 82 who received PHQ-9 scores, 18 
(22%) of them scored greater than 4. There was no statistical significance between the two groups and the 
p value resulted in 0.11. Refer to Table 2.  
Nursing Feedback results 
Neuroscience nursing questionnaire post implementation. From 8/18/2020 to 9/11/2020, the 
NSRNs completed a Likert-Scale based questionnaire about the new PHQ-9 screening process. A total of 
85 RN’s completed the questionnaire. For each statement, the RNs had to choose from the following 5 
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answers and their respective scores to describe their feelings about the particular statement: 1- Strongly 
disagree; 2- Disagree; 3- Neutral; 4- Agree; 5- Strongly agree.  Refer to Table 3.  
Neuroscience nursing open-ended questions. The first statement: “Please explain any difficulties, 
frustrations or any other problems that occurred while implementing the PHQ-9,” provided 30 answers 
out of 85 total RNs who submitted feedback. The second statement: “Please provide or explain any 
alternatives or improvements to the current screening process, provided 17 answers out of 85 total RN 
participants.” Refer to Table 4. 
Discussion 
The PHQ-9 depression screening tool was implemented through the NSRNs to compare outcomes 
with the SCC who previously conducted PHQ-9 screenings. Outcomes were based on the previously 
mentioned four objectives to evaluate the change in process. Analysis revealed consistency with the 
literature as NSRNs were capable of effectively screening for depression in stroke patients using the 
PHQ-9; however, adjustments in the hospital’s depression screening protocol could improve upon the 
lack of significance observed when comparing outcomes between the SCC and NSRNs.  
When comparing the number of PHQ-9 screenings obtained out of the total number of acute stroke 
patients in 2019 to the number of screenings obtained out of the total number of stroke patients from 
2020, there was no significant difference in the number of missed screenings (Table 2). Interestingly, 
there was clinical improvement in the amount of missed screenings during the weekend days (Saturday 
and Sunday) when comparing the NSRN data versus the SCC. Despite having 5 more stroke patients 
discharged over the weekend, the NSRN group missed only 15.6% of the screenings versus the SCC who 
missed 37% of screenings in 2019. Although there was not an overall significance in the percentage of 
missed screenings during the change in process, it is promising that the prior difficulty observed with 
screening over the weekend improved as intended. 
As previously mentioned, until 2018, TJC recommended that depression screening be mandatory in 
stroke patients within the acute care setting after a stroke to maintain CSC (The Joint Commission, 2018). 
The Hospital’s stroke program includes PSD screening as a part of its ongoing metrics as both the AHA 
and ASA still recommend screening as best practice but the timing is uncertain. Though the current 
change in process examined the ability to transition the PHQ-9 screenings from the role of the SCC to the 
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NSRN, it also demonstrated key findings that suggest screening may not be absolutely needed in the acute 
setting poststroke.. 
About 1/3rd of all stroke survivors develop depression after suffering a stroke related incident 
(Karamchandani et al., 2015; Bartoli, Di Brita, Crocamo, Clerici & Carrá, 2018; Burton & Tyson, 2015; 
Dajpratham et al., 2020; Hamid & MacKenzie, 2017). One study that observed the feasibility of 
depression screening in the acute care setting obtained results from 211 eligible patients with 75% of 
them being screened using the PHQ-9. The average time for screening was 2.5 days after admission. 
When comparing the researchers results with the current study, a similar number of stroke patients were 
obtained (174 and 128 from 2019 and 2020, respectively) and the average day screened was 4.76 in 2019 
and 2.73 in 2020, similar to the researcher’s 2.5-day average. The researcher’s average PHQ-9 score was 
only 3 and the cut-off score for patients to be considered depressed was a score > 4. Even so, they 
mention that 1/3rd of all stroke patients screened were positive for depression, which aligns with popular 
data (Karamchandani et al., 2015). The current hospital system showed that only 12.6% of all patients 
screened in 2019 met the criteria for further work-up and potential psychological evaluation. A higher 
percentage of patients met the depression criteria in 2020, resulting in 22% of all stroke patients screened. 
The exact Pearson Chi-Squared test p value was 0.11 demonstrating no significant difference among the 
two groups for this study (Table 2). Though the above results do not represent 1/3rd of their respective 
groups for suspected depression, they still represent a clinically significant amount of patients who 
present an early depressive risk. In addition, the well-accepted statistic that states about 1/3rd of all stroke 
patients develop depression accounts for individuals up to a year after their stroke, not specifically within 
the acute phase of recovery (Hackett & Pickles, 2014).  Though the overall PHQ-9 score averages were 
below the cut-off score for suspected depression, the frequency for depressive symptoms in the acute 
phase poststroke still demonstrated between 10 and 25% between the 2019 and 2020 data, making it 
difficult to recommend ridding of screening entirely in the acute poststroke setting.  
Further exploration of alternative screening tools like the stroke aphasia depression questionnaire-
hospital version (SADQ-H) and implementation of an embedded EMR notification to remind nurses to 
screen needs investigated. One China study examined 270 ischemic stroke patients through a prospective 
study conducted a little over a year. They initially obtained baseline data within the first two-weeks 
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poststroke including screening for depression with the stroke aphasia depression questionnaire-hospital 
version. A second assessment was completed at three months and a cut-off score of > 18 was used to 
determine PSD. Aphasia was determined using the Aphasia Quotient (AQ) rating. At baseline, 59.3% of 
patients demonstrated an aphasic symptom and the incidence of PSD was 47.5% compared to the non-
aphasic patients who had an incidence of PSD of 29.1% (Wang et al., 2018). Those with aphasia at 
baseline had higher incidence of PSD at baseline and three months poststroke. The current hospital 
resulted with 16.9% and 7.8% of patients who were, “Unable to be assessed,” due to aphasia or cognitive 
impairment in 2019 and 2020, respectively. The use of the SADQ-H could have shown greater incidence 
of PSD since these patients were unable to be properly assessed using the limited PHQ-9.  Of 
consideration, the China study could not exclude the possibility that nursing staff were unable to 
distinguish between insomnia, irritability, poor appetite, anxiety and depressive symptoms, adding to the 
bias of PSD to an unknown extent.  
Further, aside from considering the use of the SADQ-H, other tools like the well validated 
depression prediction scale (DePres) could offer an even more efficient, practical intervention for 
predicting the development of depression poststroke, specifically major depressive disorder. Given the 
decreasing length of stay stroke patients now experience in the hospital setting, a prediction instrument 
was designed by researchers (De Man-van Ginkel et al., 2013). Since depression symptoms are often 
difficult to discern from other stroke outcomes as previously mentioned, it was thought that a depression 
prediction tool would better serve as an intervention for those in the acute setting. Although the original 
developed DePres presented accurate outcomes, a recent study further investigated its accuracy for use 
(Hirt et al., 2020). Upon analyzing several variables associated with risk factors for depression after 
stroke, the DePres scale was created and included the following questions when assessing stroke patients: 
Does the patient have history of previous psychiatric disorders?; Does the patient have medical history of 
hypertension?; Does the patient have medical history of angina pectoris? And to what extent does the 
patient need help with dressing (part of Barthel Index)? Each of these is scored and totaled offering 
feedback about a particular patient’s risk for major depression at approximately two months poststroke. 
The recent study had nurses assesse 93 stroke patients at baseline within the first week following stroke 
using the DePres. At 6-8 weeks poststroke, the patients were provided with a formal psychiatric interview 
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by a separate, blinded researcher to determine depression. They presented an overall prevalence of major 
depressive disorder in 18.3% of the patients. The predictive score for the DePres was best at a cut-off 
score of 0 (Specificity 0.74 and sensitivity 0.64) and results were comparable to the internationally known 
prevalence of major depressive disorder at 13% according to DSM V criteria within six weeks after stroke 
(Hacket & Pickles, 2014). The DePres is particularly useful as it does not require any patient interview 
and predicts depression soley from a patient’s history and physical capabailites. Such a tool could 
mitigate the need for an additional nursing intervention like a patient interview, reducing resources 
required to assess for depression. Even so, the study excluded patients with cognitive and communicative 
impairments. Further screening with a tool like the SADQ-H would still need completed to evaluate all 
patients.  
After such changes, if screening continues to demonstrate a lack of significance in identifying 
depression in the acute care setting, then removing the screening intervention should be considered. A 
future study that would track depression screening in stroke patients from the acute care setting and up to 
the first year poststroke would better identify the ability of the PHQ-9 or other screening tools to detect 
depression later in the recovery process of stroke.  
The NSRNs did demonstrate increased knowledge of PSD and the process change was well 
received. Though the new process contributed more time and added an extra job to the NSRNs, most of 
them felt confident completing the intervention and answering patient questions regarding stroke recovery 
specific to depression.  
There was no significant difference in the number of psychiatric referrals while in the hospital when 
comparing the SCC’s data and the new neuroscience nursing data for 2020 (Table 2). The psychiatric 
evaluations were not always a result from the PHQ-9 screening score itself. Other psychiatric processes 
were present warranting a consult by the attending physician. Within the pretest group, five patients did 
not meet criteria to warrant an inpatient psychiatric consult, but their scores earned a psychiatric referral 
at the rehab clinic upon discharge. Another three patients refused psychiatric evaluation when their scores 
warranted a consultation by the SCC. For the posttest period 4/23/2020 to 7/31/2020, two of the six total 
psychiatric consultations were because of the patients having delirium, another three had previous history 
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of either major depression or bipolar disorder, and only one had a referral made directly because of a high 
PHQ-9 score (Score= 10).  
Limitations 
As implementation of the PHQ-9 depression screening tool progressed from the SCC’s responsibility 
into the NSRN’s role, there were some unavoidable limitations that altered the course of the process 
change. The biggest obstacle during the implementation phase involved the rapid changes associated with 
the SARS-Cov2/COVID-19 viral pandemic that occurred in Ohio beginning on March 9th when a state of 
emergency was issued by Governor Mike DeWine. Soon after, changes began occurring within the 
hospital to prepare the staff for the potential influx of positive SAR-Cov2 patients. Despite new education 
for nurses and staffing changes, the director for critical care services agreed to proceed with the transition 
of the PHQ-9 depression screen from the SCC into the nursing role.  
The pandemic could have primarily affected NSRNs within the NIME, as 18 of the 33 beds were 
converted for COVID-19 patients beginning on 3/18/2020. Despite such changes, there were only 3 
NSRNs who responded through the open-ended questions that the screening was difficult directly due to 
the onset of the COVID-19 pandemic (Table 4). At least another 10 RNs mentioned feeling overburdened 
or without enough time to complete the screening, which may have included aspects of the COVID-19 
pandemic. 
To further understand the impact from the pandemic, the hospital statistician provided data regarding 
the number of stroke patients who were also coded with a stroke diagnosis. Within the provided 
timeframe for the project (April through July 2020), there were 181 primary strokes (212 if trans-ischemic 
accidents (TIAs) were included). Of the 181, none were diagnosed with COVID-19. As a side note, about 
2/3rd of COVID-19 patients were given the primary diagnosis of COVID-19 since it was so severe. When 
the stroke coding definition was filtered to include strokes coded at any position, not only primary, there 
were 233 strokes (265 including TIAs), 2 of which were also diagnosed with COVID-19. Even so, the 
same NSRNs who were taking care of standard neuroscience floor patients with stroke, were also taking 
care of the COVID-19 patients on the neighboring COVID-19 unit depending on their scheduled shift. 
Despite the low incidence of COVID-19 positive patients with stroke, NSRNs were still presented with 
direct involvement with COVID-19 patients and the stress that accompanied the transition.  
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Audits on stroke patients were completed at least three days a week to ensure reminders were 
provided to RNs who had eligible patients for screening. In addition, the daily stroke list was emailed to 
each NSRN lead and all charge RNs were provided with a copy of the list and those who still needed 
screening were highlighted on the list. Verbal reminders were also provided. Last, the charge nurses also 
added depression screening to the stroke order checklist, which was completed on every stroke patient. 
These multiple layers of reminders is likely not sustainable. This barrier could be mitigated by 
integrating a notification in the EMR. RNs spend much of their time regularly charting and using the 
technology to remember medication schedules and new orders placed by physicians. One qualitative 
explorative study assessed nursing feedback regarding the usefulness of EMR alerts through nursing 
interviews. The majority of nurses confirmed that alerts and EMR notifications enhanced patient safety 
and templates or checklists that required nursing attention improved completeness of EMR notes 
(Tubaishat, 2019). For any known stroke positive patient, a push-style notification prompt/banner could 
be implemented to alert the patient’s RN that he or she needs to screen a patient prior to discharge. A 
notification could prompt the RN at least once a shift until completed and logged.  
Conclusions 
The primary intention of the project was to observe the changes in screening frequency when 
transitioning the role of screening from the SCC to the NSRNs. This project demonstrated that shifting 
responsibility to the NSRNs resulted in no change in the number of overall depression screenings but did 
result in a mildly significant decrease in the number of missed screenings over the weekend. The 
institutionally driven project not only demonstrated that the NSRNs were effective at implementing the 
PHQ-9, but that the depression screening process needs further developed to include stroke patients with 
aphasia and an improved depression screening EMR alert system. This process will continue to be 
observed over time to detect any trends and include a larger population.  
Another important finding from this project was the number of patients who screened positive for 
depression during the immediate poststroke period. Current guidelines recommend that these patients 
should be screened for depression during this timeframe (Yildirim & Ones, 2019). Additionally, current 
statistics show that one-third of stroke patients will develop depression (ref here). Despite these 
recommendations, both the pre and post data from this QI project showed that most of those screened in 
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the hospital in the immediate poststroke period did not present with PHQ-9 scores consistent with 
depression (Cut-off score > 4).  This inconsistency suggests that either the depression has not yet 
developed in the course of the disease or the current screening tool that was utilized, the PHQ-9, did not 
capture this population.  
The PHQ-9 tool is currently designed for those with symptoms that have persisted greater than 2 
weeks. This is closely based off of the DSM V criteria for depression, which states that a person must 
experience five depressive symptoms nearly everday within the previous two weeks. As the average 
length of stay for the stroke patient data sets were 6.89 and 4.89 days in 2019 and 2020, respectively, the 
PHQ-9 would have been assessing for depressive symptoms prior to most patients’ stroke incident. The 
PHQ-9 has shown validity in detecting depression when modified to ask patients’ questions as they 
pertain to the time since their stroke (Karamchandani et al., 2015). Despite this, it remains difficult to 
know if their depressive symptoms started prior to the stroke or as a result of the stroke itself, especially 
as depression can often be confused with such conditions like apathy or fatigue.There are no current 
screening tools that have been shown to be valid and reliable indicators of depression over this short of a 
time frame. Although screening in the hospital does uncover patients who screen positive, the prevalence 
of these patients is often low, is often confounded by pre-existing mental health conditions, and rarely 
requires immediate inpatient intervention with a psychiatric provider.  These findings question whether 
current guidelines should advise depression screening in the immediate poststroke period or if screenings 
should start in the outpatient setting. 
Section Five: Recommendations and Implications for Practice 
Implications for Practice 
The project required professional collaboration and inquiry among healthcare providers, patients, 
hospital administration, extensive literature review and knowledge of patient care for those who suffered 
a stroke, comprehension of how stroke relates to depression, the screening tools available that help detect 
depressive symptoms, development of education for nurses, use of technology for data collection and 
efficiency, and overall implementation of a new process and evaluation of data collected. To adequately 
engage in the intervention, eight of the Doctor of Nursing Practice (DNP) Essentials were incorporated to 
demonstrate competent knowledge regarding depression screening in stroke patients. 
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Essential I includes the use of science-based theories and concepts to, “Describe the actions and 
advanced strategies to enhance, alleviate, and ameliorate health.” (American Association of Colleges of 
Nursing [AACN], 2006). This project used nursing theory and evidence-based recommendations for 
stroke care to attempt to improve the identification of depression in stroke patients. Essential II utilizes 
scientific findings in nursing to help develop and evaluate care delivery approaches that meet current and 
future needs of patient populations. The stroke population is susceptible to developing depression and the 
current project evaluated the care delivery of the PHQ-9 screening tool within stroke patients. In addition, 
efficient and advanced communications methods were used to guide the project forward and transition the 
screening role from the SCC to the NSRNs responsibility. 
Essential III involved the use of analysis and ability to critically appraise existing literature to 
determine the best overall evidence suitable for practice. As previously noted, of the 66 total articles 
surveyed, 12 offered key interventions and methodologies that were synthesized to offer support for the 
project’s process change. In addition, the project included application of relevant findings to improve 
practice and used information technology to collect appropriate and accurate data for detecting depression 
in stroke patients. Essential IV primarily involves the ability to use information technology to effectively 
analyze, organize and evaluate patient data and health information. Patient EMR’s were used by the 
NSRNs to record PHQ-9 scores and these scores were tracked and transferred into software programs like 
Microsoft Excel for further conversion into meaningful data. Essential V, which pertains primarily to 
health policy development, did not directly apply to the following project. For essential VI, 
interprofessional collaboration, hospital physicians, nursing leadership and the nursing staff were 
regularly in communication with the project leaders during the transition of the PHQ-9 screening tool 
from the SCC to the NSRN’s responsibility. Although not necessarily a direct portion of the projects 
purpose, essential VII played a role in stroke education. Upon implementing the PHQ-9, NSRNs were to 
educate stroke patients on risk reduction and explain the risk factors associated with not only stroke 
prevention but also depression. 
Last, a primary component of essential VIII encompasses advanced practice nursing such as the 
ability to demonstrate advanced levels of clinical judgement, systems thinking, and accountability in 
designing, delivering and evaluating evidence-based care to improve clinical outcomes. For the above 
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project in an acute hospital setting, best evidence for stroke related depression was reviewed to create an 
education module and quiz for the NSRNs to complete prior to beginning their new role in screening for 
depression. It was imperative that each NSRN had taken the education and demonstrated the knowledge 
to further educate patients on depression after stroke. 
The QI project was partially driven by the institution’s plan for further expansion and growth of a 
future stroke care team. As a CSC, the neuroscience department aims to further expand its stroke care 
with the development of a stroke specific team in the future. Currently, the SCC has solely worked with 
the neurology and neurosurgery departments to develop stroke protocols and perform bedside education 
and interviews to collect data for stroke patients. Part of this data included delivery of the PHQ-9 to 
patients to screen for depression. Although a single task, depression screening can be completed by 
several different health providers including nurses. Previously, there had been attempts with having the 
social work department complete the screenings. Unfortunately, like the SCC, social workers were not 
always available during the weekend hours and consistency in screening was lacking and the process 
failed to show any promise. 
Nurses are with patients throughout the entire week and provide most of the bedside interaction with 
patients and families. The transition of the role for depression screening from the SCC to the NSRNs had 
been something anticipated but never fully formed until now. The PHQ-9 intervention for the project is 
going to continue as an ongoing process for the NSRNs. Using feedback provided by the NSRNs 
regarding the new task as well as the overall data regarding incidence of depression, future changes may 
be considered to improve the process and care including: A different or additional screening tool that also 
has the ability to assess for aphasic patients, better EMR recording with electronic prompts and 
reminders, improved notification to attending physicians when scores warrant further work-up, and the 
addition of a protocol with practice recommendations for treatment to guide the physicians as needed. 
Dissemination 
As previously noted, the current Hospital implements PSD screening as a part of their system’s 
metrics and recommendations under AHA and ASA’s guidelines. Despite the intervention being 
institutionally driven and recommended by the AHA and ASA, many other acute inpatient hospital 
systems could benefit from the dissemination of the evidence. Other hospitals systems that want to better 
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understand the importance of PSD screening in the immediate poststroke setting may benefit from the 
above outcomes. In addition, outpatient clinics could use inpatient evidence to better understand the 
prevalence of depression being observed in the acute setting. Although the direct process of screening 
through the RN staff would be mostly impactful during a similar inpatient setting, any venue of healthcare 
that encounters stroke patients can use these results to better understand depression after stroke. As the 
Hospital’s results did not correlate with the current knowledge that 1/3rd of stroke patients develop stroke, 
it is possible that many of these patients may still develop depression later in their recovery. 
As the new process develops, PSD screening will be conducted by all RNs who take care of stroke 
patients in the hospital. Though these other units have yet to take part in the new process, dissemination 
of the results would bring awareness about the screening process and introduce the intervention for future 
implementation. Last, the Hospital’s chief nursing officer (CNO) and administration, unit coordinators, all 
RNs, and National Guidelines like the AHA and ASA would benefit from such findings that demonstrate 
PSD may not be as frequently observed or as definitive as a diagnosis in the immediate poststroke setting. 
Findings like the above project have the potential to influence not only policy within a single hospital but 
also National guidelines to better inform healthcare.  
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Figure 1. Evaluation Table of Literature 
First Author 
(year) 
Design Methods Sample Setting Variables Studied Measurement Data Analysis Overall Appraisal 
Burton (2015) Level 1 SR 30 Publications and 27 screening 
tools 
IV: Several screening tools 
used to assess for mood 
disorders DV: Patients 
receiving a particular 
screening tool 
(a) Time to administer and score the measure: ≤5 
min (score 2); 6–10 min (score 1); ≤11 min (score 
0). 
(b) Initial costs for purchase of the measure (e.g. 
starter kit including manual): 2 = freely available; 
1 = cost < £100; 0 = cost ≥£100 or unavailable. 
(c) Additional cost per record form: 1 = no 
additional 
Costs; 0 = additional cost or unavailable. (d) Need 
for specialist training to administer and 
score the measure: 1 = no specialist training 
required; 0 = specialist training required. 
Extracted data from the participant 
samples, settings, selection criteria, tools 
tested, type of disorder assessed and 
sensitivity (≥0.8) and specificity (≥0.6).  
Demonstrates valid use for PHQ-9; 
Also adds support for investigating 
better alternatives in stroke patients. 
Hirata (2016) Level 4 
NHANES survey 
samples- MCD. 
17,132 samples 2005-2010 
678= Stroke Survivors 546= 
Completed PHQ-9 
87 “Neighbors” depression group 
or prototype non-depression group 
IV: Forest Model 
DV: Those surveyed in 
NHANES 
Stroke was self-reported. Depression defined 
with PHQ-9 score > 10.  
2 Logistic Regression Models: 
sociodemographic factors and Major 
Medical Comorbidities 
Good evidence for examining 
predictors of depression in stroke; 
Uses PHQ screening. 
Meader (2014) Level 1 MA 24 studies on 2,907 stroke 
surviving participants 
IV: PHQ-9 
DV: Stroke Patients 
Validation of: BDI, PHQ-9, PHQ-2, two stem 
questions, GHQ-12, GHQ-28, CES-D, GDS, GDS-15, 
Zung depression self-rating scale, HADS-D, and 
HDRS. 
Bivariate & 
HSROC Meta-An were conducted using 
R 2.15.1 using the MADA 
and HSROC packages. 
Validates PHQ-9 is suited well for 
screening stroke depression but 
always recommend f/u w/ psych. 
Rogers (2017) Level 5 Review None IV: 3 primary useful tools: 
PHQ-9, CES-D and HDRS 
DV: Stroke Patients 
N/A No analysis due to review PHQ-2 best for RNs as it can be 
administered quickly and is followed 
by PHQ-9 if the initial screen is 
positive. Only a review paper and not 
definitive research. 
Berg (2018) Level 4 
Retro and 
prospective pre 
and post review 
2010: 105 stroke patients-MR’s 
used to assess 
2012: 112 Stroke patients-Nurse 
scored ward  
IV: DEPS & Barthel Index 
DV: Stroke Patients in 2010 
and 2012 
Obs: 1) Obs only; 2) At least some discussion of 
depressive symptoms; 3) A screening Instrument; 
4) Info. Received from a next of kin. 
3 Points of measurement: 1) inpatient stay; 2) 
Outpatient < 9 months; 3) Outpatient between 9-
18 months poststroke 
Person’s chi-squared to compare samples 
2010 and 2012; t-Tests used to compare 
means and Mann-Whitney U Tests when 
necessary  
Demonstrates the value in 
assessment and scheduling a f/u 







2012: 53 stroke patients and 43 
nurses. 
IV: PHQ-9 
DV: Stroke patients with 
ICH or IS 
 
 
-0 to 4= no depression, 5 to 9= mild depression, 
10 to 14= moderate depression, 15 to 19= 
moderately severe depression, 20 to 27= severe 
depression.  
-PHQ-9 and the PHQ-2 showed excellent results 
with respective sensitivities of 91% and 83% and 
respective specificities of 89% and 84% for major 
depression. 
The interrater reliability test, 
Y-retest reliability and internal consistency 
of the PHQ-9 were good. Concurrent 
validity was moderate. 
-Optimal cut-off score 10. 
RNs provided screening adequately 
as evidenced by good clinical utility.  
 
93-100% of RNs believed the 10.7 
minute time frame for administering 
PHQ-9 was acceptable and easy to 
use.  
Wang (2018) CC Level 3 147 Patients/self reported stroke 
2015 Heart and Soul Study  
IV: CES-D, PHQ-2 and 9, 
and Whooley Questions 
DV: HAS Patients 
C-DIS used to diagnose depression and 
administered same day as screening tests with 
administrator blinded to results. Other measures 
like age, race, education, social history, income 
and medical history were self-reported. 
Baseline characteristics among participants 
with and w/out depression compared with 
t-Tests, X2 for binary or categorical 
variables and Fisher exact test for sample 
sizes ≤ 5.  
Success with PHQ-9, but they deemed 
Whooley questions best at identifying 
depression. 
Li (2016) CC level 3 410 Chinese Stroke patients within 
7-14 days poststroke 
IV: PSD Early Depression 
Measure (35-item) self-
rated scale 
DV: 410 patients with 
stroke  
Demographic and clinical characteristics; 
35-item PSD early depression measure-5 point 
Likert response 0-4 for each item 
Descriptive: Freq. Stats with percentages 
for categorical var., mean and STD for 
continuous var.  
Well developed, reliable data 
regarding the particular 35-item 
detection tool.  
-No PHQ-9 
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EFA and CFA procedure used to evaluate 




RCC level 3 158 patients admitted between 
02/01/2013 and 04/15/2013 with 
no medical condition precluding 
screening. 
IV: MPHQ-9 
DV: 158 patients  
PHQ-9 modified to examine depressive symptoms 
since hospitalization. Social workers 
implemented screening. Further assessment 
warranted if scores > 4. Measuring overall 
responses. 
Descriptive stats for all patients were 
presented as frequencies for nominal and 
categorical data. 
Univariable and multivariable logistic 
regression determined factors associated 
with MPHQ-9 screening (P<0.2). 
-PHQ-9 able to identify PSD, but the 
threshold score was arbitrary and 
more than a 1/4 of patients were not 
screened.  
McIntosh (2017) RCR Level 4 79 convenience sampled patients 
with acute stroke 
IV: PHQ-9 
DV: Stroke Patients 
Recordings of patient responses from the chart 
review. Audits included collection of pt. Age, race, 
gender, comorbid conditions, type of stroke, PHQ-
9 score and depression severity.  
Parametric stats used to test for 
relationships among variables. Combo of 
descriptive, nonparametric, and parametric 
stats.  
Person’s chi-squared analysis was used to 
test the association between PSD, 
demographic data, stroke characteristics, 
medical history, PHQ-9 category and 
protocol variables.  
PHQ-9 good to determine depression 
in stroke patients when implemented 
by nurses.  
However, only 2 months were 
conducted, and a different hospitalist 
was on the unit each week possibly 
failing to communicate the proper 
protocol to implement.  
Lewin-Richter 
(2015) 
LCS level 3 96 inpatient rehab stroke patients 
at baseline. 
71 of the original 96 present after 6 
months for study 
IV: GDS-15 and SCID 
DV: Stroke Patients 
Baseline GDS-15 measured with ≥5 depicting DS; 
At 6-month f/u, reassessment of DS using GDS-15 
over telephone.  
Forward logistical regression analysis used 
to determine the predictive value of GDS-
15. 
A two-tailed 
p-value <0.05 indicated statistical 
significance. 
Did not use PHQ-9 and Hem. Stroke 
pts. were excluded. Pts. first assessed 
in inpatient rehab, not acute phase 
like my project is focused. 
Dajpratham 
(2020) 
Level 3 115 stroke patients (63 male and 
52 female) ≥ 45 yrs old; first time 
stroke; stroke duration 2 weeks-2 
years; adequate cognitive health 
and Thai speaking;  
IV: Thai PHQ-9 and 
psychiatric interview 
(Psych interviewer blind to 
PHQ-9 score)—Both given 
same day 
DV: Stoke Patients- Normal 
and depressive Groups 
Thai PHQ-9; Cut-off score ≥ 9 signified MDD 
(sensitivity= 0.84 and specificity= 0.77); Cut-off 
score ≥ 6 for depression diagnosis.  
PHQ-9 scores and stroke duration 
calculated by Mann-Whitney U test; t-test 
compare depression group vs. normal 
group scores (p value < 0.05);  
PHQ-9 to accurately predict PSD 
compared to standard psych 
interview. RNs to be able to use PHQ-
9 as opposed to psych evaluation 
LEGEND: IV= Independent Variable; DV= Dependent Variable; (M)PHQ-9 (2 or 8)= (Modified) Patient Health Questionnaire; MCD= Multiprobability Cluster Design; MR= Medical Record; LCS= Longitudinal Cohort 
Study; NHANES= National Health and Nutrition Examination Survey; C-DIS= National Institute of Mental Health Diagnostic Interview Schedule; PSD= Poststroke Depression; BMI= Body Mass Index; MA= Meta-
analysis; SR= Systematic Review; GHQ-12 (28)= General Health Questionnaire; CES-D= Center of Epidemiological Studies-Depression Scale; GDS (15)= Geriatric Depression Scale; HADS-D= Hospital Anxiety 
Depression Scale; HDRS= Hamilton Depression Rating Scale; HSROC= Hierarchical summary receiver operating characteristic; MADA= Meta-analysis of Diagnostic Accuracy; DEPS= Depression Scale; CC= Case 
Control; STD= Standard Deviation; EFA= Exploratory Factor Analysis; CFA= Confirmatory Factor Analysis; RCC= Retrospective Case Control; IS= Ischemic Stroke; ICH= Intracranial Hemorrhage; RCR= Retrospective 
Chart Review; DS= Depression Symptoms; DSM-IV= Diagnostic and Statistical Manual of Mental Disorders;MDD= Major Depressive Disorder; AUC= Area under the curve; DD= Depressive Disorder; AD= Adjustment 
Disorder 
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Figure 2. Synthesis Table.  
In poststroke patients (P), how does the implementation of the PHQ-9 depression screening tool through the nursing staff (I) compared to implementation through the stroke care coordinator (C), affect depression screening compliance (O)? 
 
Author LOE/Design # Participants Pertinent Characteristic Intervention Major Findings 
Burton (2015) 1/SR 30 pubs, 27 screening 
tools 
Scored measurements regarding 
time to deliver screen, costs, and 
personnel to identify best overall 
tool  
Several screening tools used to 
assess for mood disorders  
PHQ-9: Adequate tool for PSD but sensitivity drops to 78% when trying to examine milder symptoms. 
Effective alternatives exist as well.                                                                                               
↑ 
Hirata (2016) 4/MCD 87 from NHANES Forest Model used to identify 10 
characteristics associated with PSD 
Forest Model for PSD 17% stroke survivors encounter PSD 
 
↔ 
Meader (2014) 1/MA 24 studies on 2,907 
stroke survivors 
Examined 24 studies on 2,907 
poststroke patients 
PHQ-9 PHQ-9: (sensitivity: 0.86; 95% CI 0.70 to 0.94; 
specificity: 0.79; 95% CI 0.60 to 0.90). Always follow up with psychiatric professional if flagged.                                                                                                                                            
↑ 
Rogers (2017) 5/Lit. 
Review. 
None-Simple review Nursing focused assessment of 
PHQ-9 and other screening uses. 
3 primary useful tools: PHQ-9, 
CES-D and HDRS. 
PHQ-2: best for RNs d/t efficiency; PHQ-9 only if warranted.  ↑ 
Berg (2018) 4/Retro and 
Pros. Review. 
2010: 105 stroke 
patients- MR’s used to 
assess 
2012: 112 Stroke 
patients- Nurse scored 
ward 
Examines 3 time point for measure 
of PSD observations along with 4 
points of observation regarding 
PSD 
DEPS & Barthel Index 2010: < 50% of patients had any mood recorded; 2012: > 80% had mood recordings due to follow-ups and increased 
detection. F/U important. 
↔ 




2012: 55 patients 
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Wang (2018) 3/CC 147 reports from 
Heart and Soul study 
Used C-DIS to officially diagnose 
depression same day as screening 
CES-D, PHQ-2 and 9, and Whooley 
Questions 
Results demonstrated success with PHQ-9 but Whooley questions were deemed best at identifying depression.                                                                                                                  ↑
Li (2016) 3/CC 410 Chinese Stroke 
patients- 7-14 days 
poststroke 
Goal to assess for PSD within 14 
days of admission 
PSD Early Depression Measure (35-
item) self-rated scale 
The researchers were able to identify PSD symptoms avg, 11 days poststroke. ↔ 
Karamchandani 
(2015) 
3/RCC 158 stroke patients Social worker-implemented 
modified PHQ-9 
MPHQ-9 >1/3 of all IS and ICH patients screened positive for depression or >4.                               ↑ 
McIntosh (2017) 3/RCR 79 acute stroke 
patients 
Chart Reviews: Highest % of 
identified PSD of all studies 48% 
PHQ-9 PHQ-9 useful with nurses implementing but short time period and consistent management.                                                                                                                                  ↑ 
Lewin-Richter 
(2015) 
3/LCS 96 IRS patients at 
baseline. 
71 IRS @ 6 months 
for study. 
Only study to show PSD at 
inpatient rehab and also present at 
6 months with significant 
percentage 
GDS-15 and SCID 42.43% who scored above the cut-off on GDS-15 met DSM-IV criteria for depressive disorder at 6 months.  ↔ 
Dajpratham (2020) 3/CC 115 stroke patients Compares ability of PHQ-9 to 
detect depression against DSM-V 
criteria for diagnosis of depression 
Thai PHQ-9 Thai PHQ-9 acceptable for detecting a mixture of MDD, AD, in stroke patients using summed-score based diagnosis for 
depression with cut-off score ≥ 6 signifying depression.                                                                                                                                      
↑ 
LEGEND: (M)PHQ-9 (2 or 8)= (Modified) Patient Health Questionnaire; MCD= Multiprobability Cluster Design; MR= Medical Record; LCS= Longitudinal Cohort Study; C-DIS= National Institute of Mental Health Diagnostic Interview Schedule NHANES= National Health and 
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Table 1.  






   
 
  
Table 1. Sample Characteristics (N=107) on Demographics  
 
Characteristic n (%) 
Male 18 (16.82) 
Female 87 (81.31) 
Non-Binary 1 (0.93) 




<26  26 (24.30) 
26-30 29 (27.10) 
31-40 27 (25.23) 
41-50 19 (17.76) 
51-60 5 (4.67) 
> 60 1 (0.9) 
Experience, years   
< 3 54 (50.57) 
4-8 22 (20.56) 
9-15 16 (14.95) 
16-20 4 (3.74) 
> 20 11 (10.28) 
Employment Status  
Flex 8 (7.48) 
Single Hospital Staff 97 (90.65) 
Travel  2 (1.87) 
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Title: Comparison of PHQ-9 Screening Data between Pretest (2019) and posttest (2020) 
  
Table 2. Comparison of PHQ-9 Screening Data between Pretest (2019) and posttest (2020) 
 




P Values  
Male, n (%) 74 (43) 64 (50)   
Female, n (%) 98 (56.9) 64 (50)   
NIME, n 73 63   
NPUE, n 75 46   
NIUE, n 24 19   
IS, n (%) 141 (81.9) 106 (82.8)   
ICH, n (%) 31 (18) 22 (17.2)   
Age-avg years, n 65 70   
Screened, n (%) 134 (77.9) 104 (81.25) 0.56‡  
Missed, n (%) 38 (22.1) 24 (18.8)  
UTA, n (%) 29 (16.9) 10 (7.8)   
Weekend Screened, n (%) 17 (63) 27 (87.1) 0.08‡  
Weekend Missed, n (%) 10 (37) 5 (15.6)  
Psych Referral, n (%) 8 (4.7) 6 (4.7) 0.99‡  









Scored > 4 on PHQ-9, n (%) Yes: 13 (12.6) 
No: 90 (87.4) 
Yes: 18 (22) 
No: 64 (78) 
0.11‡  









‡ Chi-square test 
NIME: Neuroscience intermediate care unit 
NPUE: Neuroscience progressive care unit 
NIUE: Neuroscience intensive care unit 
UTA: Unable to assess due to aphasia, cognitive deficit etc… 
IS: Ischemic Stroke 
ICH: Intracranial Hemorrhage/Hemorrhagic Stroke 
Note. For the overall patient population, patients discharged on weekends and status of scoring on the PHQ-9, the distribution 
of status of screening and referrals stratified by time relative to implementation of the intervention. Counts and column 
percentages are presented. Also presented are p values for exact Pearson chi square tests for differences in pre and post 
percentages. 
48 






















Table 3. NSRN Likert-scale Feedback  
NSRN Responses n= 85 
NSRN Statements n, (%) 1-Strongly 
Disagree 
2-Disagree 3- Neutral 4- Agree 5- Strongly 
Agree 
1) The PHQ-9 was easy to administer  1 (1.18) 4 (4.71) 29 (34.12) 43 (50.59)* 8 (9.41) 
2) The PHQ-9 was beneficial to stroke care 1 (1.18) 3 (3.53) 26 (30.59) 45 (52.94)* 10 (11.76) 
3) The PHQ-9 provided accurate results 1 (1.18) 2 (2.35) 40 (47.06)* 38 (44.71) 4 (4.71) 
4) I felt prepared to deliver the PHQ-9 1 (1.18) 9 (10.59) 27 (31.76) 40 (47.06)* 8 (9.41) 
5) I felt confident answering patient’s questions 
about the PHQ-9 
1 (1.18) 5 (5.88) 26 (30.59) 46 (54.12)* 7 (8.24) 
6) I would recommend continued use of the 
PHQ-9 
1 (1.18) 7 (8.24) 27 (31.76) 43 (50.59)* 7 (8.24) 
NSRN: Neuroscience nursing staff 
*Denotes highest response from statement 
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Table 4. NSRN Open-ended Qualitative Feedback 
Total NSRN Responses: 85  
n, (%) 







Overwhelming d/t COVID Difficult d/t 
patient 
reasons 








Not yet completed 
PHQ-9 on patient 
*57 (67.1) 9 (10.6) 3 (3.5 7 (8.2) 2 (2.4) 1 (1.2) 2 (2.4) 4 (4.7) 













on designated day 
Used on all 
patients 
Request an alternative tool be used 
*68 (80) 4 (4.7) Other entirely: 5 (5.9) 
Combo: 2 (3.5%) 
1 (1.2%) 1 (1.2%) 1 (1.2%) 3 (3.5%) 
NSRN: Neuroscience nursing staff 
*Denotes highest response total. 
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Appendix A. PHQ-9 Questionnaire Sample (National University of Natural Medicine, 2018). 
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Appendix B. The Johns Hopkins Nursing Evidence-based Practice Model (JHNEBP) (Dang & Dearholt, 
2017).  
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Appendix C. Agree II item for scoring guidelines (Agree II, 2009). 
  
53 





Appendix D. The Tidal Model (Barker and Buchanan-Barker, 2010).  
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Appendix E. PHQ-9 score driven algorithm for NSRN. 
 
